Startups
Edit
Aspyrian Therapeutics
https://www.aspyriantherapeutics.com/Last activity: 24.08.2018
Probably Closed
Overview
Location
United States
Total raised
$59.35M
Founded date
2010
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Mar 10, 2016 | Series B round | $40M | |
| Jul 28, 2015 | Series A round | $4.25M |
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 20, 2017 | Aspyrian Therapeutics Closes $15.1M Series B-1 Financing | Aspyrian Therapeutics, Inc., a San Diego, CA-based biotechnology company developing precision-targeted cancer therapies based on the proprietary Photoimmunotherapy (PIT) platform, closed $15.1m Series B-1 financing round. The funding, which... |
| Jul 20, 2017 | Aspyrian Therapeutics Raises $15.1M | San Diego-based Aspyrian Therapeutics, a biopharmaceuticals startup focused on precision-targeted cancer therapy, has raised $15.1M in a Series B-1 funding. The company said the funding came from private investors, including Hiroshi Mikitan... |
| Mar 10, 2016 | Daily funding roundup - March 10, 2016 | Icertis closed $15M Series B; Khosla Ventures invested in Avametric; Constant Therapy raised $2M On-demand massage service, Soothe closed a $35 million Series B round of funding, led by the company's previous investor, The Riverside Company... |
| Mar 10, 2016 | Rakuten CEO leads $40M investment in photoimmunotherapy startup Aspyrian Therapeutics? | MedCity News has contacted Aspyrian Therapeutics, and is awaiting more information on how the company plans to use the funding – and who invested. The company raised about $12.7 million last year, according to regulatory filings. Photoimmun... |
| Mar 10, 2016 | Aspyrian Therapeutics Raises $40M in Series B Financing | Aspyrian Therapeutics Inc., a San Diego, CA-based clinical stage drug development company, raised $40m in Series B financing. Hiroshi Mikitani, the CEO of Rakuten, Inc., made the investment through his personal companies. Mikitani is also a... |
| Jul 28, 2015 | Daily funding roundup - July 28, 2015 | Deliveroo took $70M; Kareo pulled in $55M; MacroFab closed $2M Deliveroo, a food delivery startup based in the United Kingdom, took a $70 million round, according to a report from VentureBeat. The round was led by Greenoaks Capital and Inde... |
| Jul 28, 2015 | Aspyrian Therapeutics Secures $4.25M in Series A Extension Financing | Aspyrian Therapeutics Inc., a San Diego, CA-based clinical stage drug development company creating precision-targeted therapies to treat cancer based on its proprietary Photoimmunotherapy platform, secured $4.25m as part of a Series A exten... |
| Jan 27, 2015 | Aspyrian Therapeutics Raise $8.5M | San Diego-based Aspyrian Therapeutics>, which is developing technology to treat cancer tumors, has raised nearly $8.5M in a funding round, according to a regulatory filing. Details and investors in the company were not announced. Aspyria... |
| Rakuten CEO leads $40M investment in photoimmunotherapy startup Aspyrian Therapeutics? | San Diego biotech Aspyrian Therapeutics just raised $40 million, according to a regulatory filing, to pursue a fascinating new way to activate the immune system to kill cancer: Photoimmunotherapy. Photoimmunotherapy uses lasers to activate ... |
Reviews 0
FAQ about Aspyrian Therapeutics
When was Aspyrian Therapeutics founded?
Aspyrian Therapeutics was founded in 2010.
How much funding has Aspyrian Therapeutics raised?
Aspyrian Therapeutics has raised $59.35M in total across 3 funding rounds.
What funding rounds has Aspyrian Therapeutics raised?
Parsers VC lists 3 funding rounds of Aspyrian Therapeutics, among them a Series B round of $40M on Mar 10, 2016 and a Series A round of $4.25M on Jul 28, 2015.
What has the press written about Aspyrian Therapeutics?
Parsers VC has collected 10 articles mentioning Aspyrian Therapeutics, among them “Aspyrian Therapeutics Closes $15.1M Series B-1 Financing” (Jul 20, 2017) and “Aspyrian Therapeutics Raises $15.1M” (Jul 20, 2017).
Is Aspyrian Therapeutics still active?
Aspyrian Therapeutics is probably closed: its latest activity on Parsers VC dates from Aug 24, 2018.